AEMD Aethlon Medical Inc

$AEMD “Dilution around the corner” 😂 There’s no announced AEMD offering/ATM around the corner. The $180M PIPE is tied to the merger/NewCo financing — not some surprise AEMD ATM dumping shares tomorrow. But sure, shorts can wait for that “dilution” while paying ~800% CTB. 😂⏳

$AEMD Gap fill... company is cash poor however that merger deal is great. Read into it or at least have ai break down for you. Dilution around the corner

$AEMD MF-ERS going to sell it off before the merger and the Reverse Split.....taking stockholder equity to shit....thanks

$AEMD $AEMD — Aethlon Medical Positive Developments & Upcoming Catalysts Aethlon Medical has several positive developments that have attracted increased attention: • Definitive merger agreement with North Immunology. • Approximately $180 million oversubscribed private financing announced alongside the transaction. • Financing is expected to provide runway into the second half of 2028. • Lead program NOR-101 targets IL-13 and IL-18 for atopic dermatitis. • Phase 1a is planned for Q1 2027. • Initial safety and pharmacokinetic data are targeted around mid-2027. • Existing AEMD shareholders are expected to receive a CVR tied to potential future value from certain Aethlon legacy assets, subject to the transaction terms. • The stock has recently shown strong momentum and increased market attention.